Russell RG - Search Results

1

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

Shipman CM, Rogers MJ, Apperley JF, Russell RG, Croucher PI. Shipman CM, et al. Among authors: russell rg. Br J Haematol. 1997 Sep;98(3):665-72. doi: 10.1046/j.1365-2141.1997.2713086.x. Br J Haematol. 1997. PMID: 9332325 Free article.

2

Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism.

Rogers MJ, Chilton KM, Coxon FP, Lawry J, Smith MO, Suri S, Russell RG. Rogers MJ, et al. Among authors: russell rg. J Bone Miner Res. 1996 Oct;11(10):1482-91. doi: 10.1002/jbmr.5650111015. J Bone Miner Res. 1996. PMID: 8889848

3

Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Sati HI, Apperley JF, Greaves M, Lawry J, Gooding R, Russell RG, Croucher PI. Sati HI, et al. Among authors: russell rg. Br J Haematol. 1998 May;101(2):287-95. doi: 10.1046/j.1365-2141.1998.00687.x. Br J Haematol. 1998. PMID: 9609524 Free article.

4

Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor.

Hargreaves PG, Wang F, Antcliff J, Murphy G, Lawry J, Russell RG, Croucher PI. Hargreaves PG, et al. Among authors: russell rg. Br J Haematol. 1998 Jun;101(4):694-702. doi: 10.1046/j.1365-2141.1998.00754.x. Br J Haematol. 1998. PMID: 9674743 Free article.

5

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.

Shipman CM, Croucher PI, Russell RG, Helfrich MH, Rogers MJ. Shipman CM, et al. Among authors: russell rg. Cancer Res. 1998 Dec 1;58(23):5294-7. Cancer Res. 1998. PMID: 9850051

6

Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma.

Sati HI, Greaves M, Apperley JF, Russell RG, Croucher PI. Sati HI, et al. Among authors: russell rg. Br J Haematol. 1999 Feb;104(2):350-7. doi: 10.1046/j.1365-2141.1999.01193.x. Br J Haematol. 1999. PMID: 10050719 Free article.

7

Bisphosphonates: from the laboratory to the clinic and back again.

Russell RG, Rogers MJ. Russell RG, et al. Bone. 1999 Jul;25(1):97-106. doi: 10.1016/s8756-3282(99)00116-7. Bone. 1999. PMID: 10423031 Review.

8

The pharmacology of bisphosphonates and new insights into their mechanisms of action.

Russell RG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Croucher PI, Shipman C, Fleisch HA. Russell RG, et al. J Bone Miner Res. 1999 Oct;14 Suppl 2:53-65. doi: 10.1002/jbmr.5650140212. J Bone Miner Res. 1999. PMID: 10510215 Free article. Review.

9

Bisphosphonates: pharmacology, mechanisms of action and clinical uses.

Russell RG, Croucher PI, Rogers MJ. Russell RG, et al. Osteoporos Int. 1999;9 Suppl 2:S66-80. doi: 10.1007/pl00004164. Osteoporos Int. 1999. PMID: 10525729 Review. No abstract available.

10

Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts.

Karadag A, Oyajobi BO, Apperley JF, Russell RG, Croucher PI. Karadag A, et al. Among authors: russell rg. Br J Haematol. 2000 Feb;108(2):383-90. doi: 10.1046/j.1365-2141.2000.01845.x. Br J Haematol. 2000. PMID: 10691869 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters